Showing results (1611-1620 of 2,155) with videos related to
Sort By:
Pageof 216
Journal of Biopharmaceutical Statistics|June 20, 2022
Utilizing stratified generalized propensity score matching to approximate blocked randomized designs with multiple treatment levelsNathan Corder, Shu YangJournal of Biopharmaceutical Statistics|May 25, 2010
Analysis of time-to-event data under a two-stage survival adaptive design in clinical trialsQingshu Lu, Siu Keung Tse, Shein-Chung ChowJournal of Biopharmaceutical Statistics|May 25, 2010
Bayesian estimation for performance measures of two diagnostic tests in the presence of verification biasDavi Casale Aragon, Edson Zangiacomi Martinez, Jorge Alberto AchcarJournal of Biopharmaceutical Statistics|May 25, 2010
Residuals and outliers in replicate design crossover studiesRobert Schall, Laszlo Endrenyi, Arne RingJournal of Biopharmaceutical Statistics|November 9, 2010
Perspectives on the use of adaptive designs in clinical trials. Part II. Panel discussionNorbert Benda, Werner Brannath, Frank Bretz, et al.Journal of Biopharmaceutical Statistics|November 9, 2010
Comments on the draft guidance on "adaptive design clinical trials for drugs and biologics" of the U.S. Food and Drug AdministrationWerner Brannath, Hans Ulrich Burger, Ekkehard Glimm, et al.Journal of Biopharmaceutical Statistics|November 9, 2010
FDA draft guidance on adaptive design clinical trials: Pfizer's perspectiveChristy Chuang-Stein, Mohan BeltangadyJournal of Biopharmaceutical Statistics|December 31, 2010
Sample size determination for testing equality in a cluster randomized trial with noncomplianceKung-Jong Lui, Kuang-Chao ChangJournal of Biopharmaceutical Statistics|December 31, 2010
Distribution of odds ratio in 2 × 2 contingency table: adjustment for correlationAtanu Biswas, Jing-Shiang HwangJournal of Biopharmaceutical Statistics|March 11, 2011
Joint modeling of outcome, observation time, and missingnessMichael G Kenward, Gerd K RosenkranzPageof 216